ABDX Abingdon Health Plc

0.1119USD8.500 GBp · LSE0.00%Mkt Cap: 48.70M USDP/E: —

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturi…

Key Statistics

Company
Market Cap48.70M USD
Enterprise Value46.69M USD
Revenue (TTM)14.48M USD
Gross Profit6.82M USD
Net Income (TTM)-2.80M USD
Revenue/Share0.04 USD
Last Price0.1119 USD
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees131
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISINGB00BLF79J41
Valuation
P/E (Trailing)—
P/E (Forward)212.50
PEG—
EV/EBITDA-15.27
EV/Revenue3.23
P/S3.36
P/B6.07
EPS (TTM)-0.01 USD
EPS (Forward)0.0005 USD
52W Range
0.000065% of range0.1712
52W High0.1712 USD
52W Low0.0000 USD
Profitability
Gross Margin47.10%
Oper. Margin-25.77%
EBITDA Margin-21.12%
Profit Margin-19.36%
ROE-34.86%
ROA-19.69%
ROIC-44.00%
ROCE-28.17%
Growth
Revenue Growth26.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.12M USD
CapEx (TTM)264.69K USD
FCF Margin-13.47%
FCF Yield-4.00%
Net Debt-2.01M USD
Net Debt/EBITDA0.66
Net Debt/FCF—
Balance Sheet
Debt/Equity0.22
Current Ratio1.91
Quick Ratio1.71
Book Value/Sh0.02 USD
Cash/Share0.0092 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)0.2502 USD
Upside (mean)+123.5%
Target Range0.2502 USD – 0.2502 USD
# Analysts1
Ownership
Shares Out.252.75M
Float169.51M
Insiders30.43%
Institutions31.57%
Technical
SMA 500.1297 (-13.7%)
SMA 2000.1281 (-12.7%)
Beta0.02
S&P 52W Chg12.08%
Avg Vol (30d)84.04K
Avg Vol (10d)38.46K
Technical Indicators
RSI (14)30.6
MACD-0.3065
MACD Signal-0.3248
MACD Hist.+0.0183
BB Upper0.1221 USD
BB Middle0.1164 USD
BB Lower0.1106 USD
BB Width9.90%
ATR (14)0.0118 USD
Vol Ratio (20d)1.48x

About Abingdon Health (LON: ABDX)

›

Abingdon Health (LON: ABDX) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 131 employees.

The shares were at 8.500 GBp on 19 November 2026, up 36.0% over 52 weeks.

Its market capitalisation is 36.98M GBP.

Abingdon Health reports return on equity of -34.9%, an operating margin of -25.8% and revenue up 26.6% year over year.

It holds more cash than debt, a net cash position of 1.52M GBP. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. One analyst covers the stock, with an average rating of Strong Buy; their mean price target of 19.00 GBp is 123.5% above the current price.